| 2026-08-27 | 8-K | Form 8-K/A, Item 5.02 |
| 2026-07-29 | Press release | Download , Avantor® Reports Second Quarter 2026 Results |
| 2026-07-29 | Press release | Avantor® Reports Second Quarter 2026 Results |
| 2026-07-29 | Deck | Earnings presentation · Q2 2026 · Jul 2026 |
| 2026-07-29 | Supplement | Supplemental disclosures & Non-GAAP reconciliations · Q2 2026 |
| 2026-07-29 | Press release | Press release · Q2 2026 · Jul 2026 |
| 2026-07-29 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-29 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-29 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-17 | 8-K | Form 8-K, Item 1.01 |
| 2026-07-14 | Press release | Download , Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention |
| 2026-07-14 | Press release | Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product |
| 2026-07-01 | Press release | Download , Avantor® to Report Second Quarter 2026 Earnings on Wednesday, (opens in new wind |
| 2026-07-01 | Press release | Avantor® to Report Second Quarter 2026 Earnings on Wednesday |
| 2026-05-19 | Press release | Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory |
| 2026-05-19 | Press release | Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory |
| 2026-05-12 | 8-K | Form 8-K, Item 5.07 |
| 2026-04-29 | Press release | Avantor® Reports First Quarter 2026 Results |
| 2026-04-29 | Press release | Avantor® Reports First Quarter 2026 Results |
| 2026-04-29 | Deck | 2026 Q1 Presentation |
| 2026-04-29 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-29 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-23 | Press release | Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformat |
| 2026-04-23 | Press release | Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Tra |
| 2026-04-23 | 8-K | Form 8-K, Item 5.02 |
| 2026-04-21 | Press release | Download , Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing, A |
| 2026-04-21 | Press release | Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing |
| 2026-04-13 | Press release | Download , Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility |
| 2026-04-13 | Press release | Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility |
| 2026-04-03 | Press release | Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 |
| 2026-04-03 | Press release | Avantor® to Report First Quarter 2026 Earnings on Wednesday |
| 2026-04-01 | Press release | Avantor® Announces CFO Transition |
| 2026-04-01 | Press release | Avantor® Announces CFO Transition |
| 2026-04-01 | 8-K | Form 8-K, Item 5.02 |
| 2026-03-27 | Proxy | Definitive proxy statement |
| 2026-02-25 | 8-K | Form 8-K/A, Item 5.02 |
| 2026-02-25 | 8-K | Form 8-K/A, Item 5.02 |
| 2026-02-11 | Deck | Q4 & FY 2025 Earnings Earnings Presentation |
| 2026-02-11 | Press release | Avantor® Reports Fourth Quarter and Full Year 2025 Results |
| 2026-02-11 | Press release | Avantor® Reports Fourth Quarter and Full Year 2025 Results |